ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,967.84
-0.22%
US Tech 100
21,102.40
-0.27%
Dow Jones
42,206.82
0.08%
Brent Oil
76.125
0.00%
Bitcoin
101,656.32
-1.61%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GT Biopharma Inc (GTBP) Quote

GT Biopharma Inc

GT Biopharma Inc (GTBP)

NASDAQ
3.05
0.11
(3.74%)
Closed June 21 4:00PM
15 min delayed - Upgrade to Realtime
3.04
-0.01
(-0.33%)
After Hours: 7:59PM
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.05
Bid
2.91
Ask
3.08
Volume
18,068
2.91 Day's Range 3.05
1.72 52 Week Range 4.10
Market Cap
7.889M
Previous Close
2.94
Open
2.91
Last Trade
7
@
3.0396
Last Trade Time
Financial Volume
$ 54,346
VWAP
3.0078
Average Volume (3m)
50,529
Shares Outstanding
2,586,397
Dividend Yield
-
PE Ratio
-0.60
Earnings Per Share (EPS)
-5.09
Revenue
-
Net Profit
-13.16M

About GT Biopharma Inc

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.gtbiopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $2.94. Over the last year, GT Biopharma shares have traded in a share price range of $ 1.72 to $ 4.10.

GT Biopharma currently has 2,586,397 shares outstanding. The market capitalization of GT Biopharma is $7.60 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.60.

Ask ADVFN Intelligence (AI)

GTBP Latest News

More News

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
June 11 2025
GTBP (3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
June 11 2025
GTBP (3.74%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
June 03 2025
GTBP (3.74%)

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
May 30 2025
GTBP (3.74%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
May 29 2025
GTBP (3.74%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
GTBP (3.74%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.134.452054794522.923.042.75472922.83908294CS
40.217.394366197182.843.27992.52618672.9113514CS
120.7532.60869565222.33.27992.1006505292.5923524CS
261.0955.6122448981.964.11.724714052.59760017CS
520.030.9933774834443.024.11.722429862.60173398CS
156-84.55-96.518264840287.698.71.7230206111.00625854CS
260-161.95-98.1515151515165591.9931.7231457090.36044153CS

GTBP - Frequently Asked Questions (FAQ)

What is the current GT Biopharma share price?
The current share price of GT Biopharma is $ 3.05
How many GT Biopharma shares are in issue?
GT Biopharma has 2,586,397 shares in issue
What is the market cap of GT Biopharma?
The market capitalisation of GT Biopharma is USD 7.6M
What is the 1 year trading range for GT Biopharma share price?
GT Biopharma has traded in the range of $ 1.72 to $ 4.10 during the past year
What is the PE ratio of GT Biopharma?
The price to earnings ratio of GT Biopharma is -0.6
What is the reporting currency for GT Biopharma?
GT Biopharma reports financial results in USD
What is the latest annual profit for GT Biopharma?
The latest annual profit of GT Biopharma is USD -13.16M
What is the registered address of GT Biopharma?
The registered address for GT Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the GT Biopharma website address?
The website address for GT Biopharma is www.gtbiopharma.com
Which industry sector does GT Biopharma operate in?
GT Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.359
(-0.09%)
193.97M

GTBP Discussion

View Posts
HoldEm777 HoldEm777 2 months ago
It’s trying to hold up when a lot of others I was watching kept falling lower.
👍️0
Monksdream Monksdream 2 months ago
GTBP under $4
👍️0
HoldEm777 HoldEm777 3 months ago
Looks like bottom possibly
👍️0
glenn1919 glenn1919 4 months ago
GTBP........................................................................................................p/m
👍️0
BurgerKing82 BurgerKing82 6 months ago
Hmmm... interesting
👍️0
glenn1919 glenn1919 6 months ago
GTBP................................................p/m
👍️0
philaya philaya 1 year ago
buy the dip....
low low.
👍️0
philaya philaya 1 year ago
Got in...
Happy losing day.
👍️0
TheFinalCD TheFinalCD 1 year ago
$GTBP solid alerts@MoonMarket_ pic.twitter.com/m5nAAf63ee— THE FINAL COUNTDOWN (@THIS_TIME_X) May 21, 2024
👍️0
tw0122 tw0122 1 year ago
Didn’t participate in earlier todays squeeze but 100,000 shares available only. Nice continuation
👍️0
TheFinalCD TheFinalCD 1 year ago
GTBP https://x.com/GBearTrading/status/1792907456361713969
👍️0
Awl416 Awl416 1 year ago
LOL
👍️0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Awl416 Awl416 1 year ago
Wils
👍️0
Invest-in-America Invest-in-America 1 year ago
Regarding @RONN, no tip was given to me about it at all --- indeed, the FIRST time I heard about was from YOUR post to me over here.
👍️0
Invest-in-America Invest-in-America 1 year ago
GTBP: Nope; I simply follow the daily posts of iHub's "tw0122", who was the first to post in here on this one.
👍️0
reena969 reena969 1 year ago
I've been trying to find you Did you take the tip that was given to you?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174447373
👍️0
govprs govprs 1 year ago
Joker!!! Looks like it’s halted again
👍️0
bwrbad bwrbad 1 year ago
no future - be at 50c
👍️0
Invest-in-America Invest-in-America 1 year ago
GTBP: Halted!!
👍️0
govprs govprs 1 year ago
I’m still holding what’s all the excitement about
👍️0
Invest-in-America Invest-in-America 1 year ago
GTBP: Still holding --- 4-bagger later today??????
👍️0
tw0122 tw0122 1 year ago
Moon man summary 90% institutional ownership by Girozentrale on 1m float leaves 100,000 shares for retail to pump. June catalyst
👍️0
Otis T Otis T 1 year ago
One year price target of $153. Published post split, article available on NASDAQ.com.
👍️0
Muhbruh Muhbruh 1 year ago
$GTBP recent r/s Bio 1.34m float with 15 months of cash $8.52 cash/sh and no dilution has large pipeline and recently submitted IND application pic.twitter.com/icI6E2OapY— STOCKS Gambino (@StocksGambino) March 12, 2024
👍️0
Renee Renee 1 year ago
GTBP: effective Feb. 5,2024 a one for 30 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
Plummy Potter Plummy Potter 2 years ago
Anyone have access to the latest HCW or EF Hutton research reports?
👍️0
Triple nickle Triple nickle 2 years ago
Nice grab
👍️0
limer814 limer814 2 years ago
Sure is ,and this sudden burst in volume is telling, added today
👍️0
Triple nickle Triple nickle 2 years ago
This is the bottom folks
👍️0
Triple nickle Triple nickle 2 years ago
Weeee
👍️0
Triple nickle Triple nickle 2 years ago
A little bit
👍️0
limer814 limer814 2 years ago
Action!!
👍️0
limer814 limer814 2 years ago
The big three 0
👍️ 1
SittingPretty SittingPretty 2 years ago
saw that too. these bios are beat to hell... should eventually get back some public trust
👍️0
limer814 limer814 2 years ago
Nice buys coming in
👍️0
SittingPretty SittingPretty 2 years ago
Nice! Should be hearing something from these guys... hopefully soon.
👍️0
limer814 limer814 2 years ago
Nice buys coming in
👍️0
SittingPretty SittingPretty 2 years ago
Regret not waiting... what a crap show lol
👍️0
SittingPretty SittingPretty 2 years ago
Have to admit, grateful to accumulate at these prices. $GTBP is far along in its process with FDA and others obviously know it. That $175k Form 4 purchase filing last week was telling!
https://www.otcmarkets.com/filing/html?id=16743896&guid=2aT-knKRHtwfJth
👍️0
SittingPretty SittingPretty 2 years ago
Good morning $GTBP
👍️0
diskman diskman 2 years ago
Very interesting
👍️ 1
SittingPretty SittingPretty 2 years ago
Good Morning Did you see this? Think we're getting close to some good news. Check it out:

Charles Casamento - Executive Director & Principal - The Sage Group purchased $175k worth of $GTBP @ .35 on 6/16/2023. Filed Form 4 on 06/21/2023
https://www.otcmarkets.com/filing/html?id=16743896&guid=-HT-kenyprHRB3h

Charles J. Casamento is currently Executive Director and Principal of The Sage Group, a healthcare advisory group specializing in mergers, acquisitions, and partnerships between biotechnology companies and pharmaceutical companies, since 2007.
https://www.linkedin.com/in/charles-casamento-b1a9173
👍️0
SittingPretty SittingPretty 2 years ago
Wow, L2 going crazy. Hopefully this is the flush out and then ready for higher ground!
👍️0
SittingPretty SittingPretty 2 years ago
Absolutely! Grabbed a bunch a few mins ago. Wow! What a pullback.
👍️0
Triple nickle Triple nickle 2 years ago
Another day of adding here
👍️0
SittingPretty SittingPretty 2 years ago
Nice! I'm right here with ya loading Good day for it!
👍️0
limer814 limer814 2 years ago
Loaded some more today
👍️0
SittingPretty SittingPretty 2 years ago
Great loading day!
👍️0
WARHAMMER WARHAMMER 2 years ago
Lol
👍️0

Your Recent History

NASDAQ
GTBP
GT Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads